Uptake and metabolism of MPTP and MPP+ in SH-SY5Y human neuroblastoma cells

In Vitro and Molecular Toxicology: Journal of Basic and Applied Research

Volumn 11, Issue 1, 1998, Pages 3-14

  Song, Xiaoou ^a   Ehrich, Marion ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; METABOLISM; NEUROBLASTOMA CELL; NEUROTOXICITY;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 0031877287     PISSN: 10979336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. 3H] noradrenaline in cultured neuronal cells. Br. J. Anaesth. 71, 540-543.
2. 3H] noradrenaline from SH-SY5Y human neuroblastoma cells. Br. J. Anaesth. 72, 98-103.
3. BASMA, A.N., HEIKKILA, R.E., NICKLAS, W.J., GIOVANNI, A., and GELLER, H.M. (1990). 1-methyl-4-phenyl-tetrahydropyridine- and 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: Role of monoamine oxidase a. J. Neurochem. 55, 870-877.
4. BASMA, A.N., HEIKKILA, R.E., SAPORITO, M.S., PHILBERT, M., GELLER, H.M., and NICKLAS, W.J. (1992). 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells is enhanced by preventing glycolysis. J. Neurochem. 58, 1052-1059.
5. BIEDLER, J.L., HALSON L., and SPENGLER, B.A. (1973). Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2652.
6. BIEDLER, J.L., ROFFLER-TARLOV, S., SCHACHNER, M., and FREEDMAN, L.S. (1978). Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751-3757.
7. BITLER, C.M., ZHANG, M., and HOWARD, B.D. (1986). PC12 variants deficient in catecholamine transport. J. Neurochem. 47, 1286-1293.
8. BUCKMAN, T.D. (1991). Toxicity of MPTP and structural analogs in clonal cell lines of neuronal origin expressing B type monoamine oxidase activity. Molec. Chem. Neuropathol. 15, 87-102.
9. BURNS, R.S., CHIUEH, C.C., MARKEY, S.P., EBERT, M.H., JACOBOWITZ, D.M., and KOPIN, I.J. (1983). A primate model of parkinsonsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550.
10. CHAN, P., ELLANNEY, L.E., IRWIN, I., LANGSTON, J.W., and DI MONTE, D. (1992). MPTP-induced ATP loss in mouse brain. Ann. N.Y. Acad. Sci. 648, 306-308.
11. CHIBA, K., TREVOR, A., and CASTAGNOLI, N. (1984). Metabolism of the neurotoxic amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120, 574-579.
12. CHIBA, K., PETERSON, L.A., CASTAGNOLI, K.P., TREVOR, A.J., and CASTAGNOLI, N. (1985a). Studies on the molecular mechanism of bioactivation of the selective nigroatriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Drug Metab. Disposit. 13, 342-347.
13. CHIUEH, C.C., BURNS, R. S., MARKEY, S.P., JACOBOWITZ, D.M., and KOPIN, I.J. (1985b). Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci. 36, 213-218.
14. COHEN, G., PASKI, P., COHEN, B., LEIST, A., MYSTILINEOU, C., and YAHR, M.D. (1984). Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkey. Eur. J. Pharmacol. 106, 209-210.
15. DAVIS, G.C., WILLIAMS, A.C., MARKEY, S.P., et al. (1979). Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1, 249-254.
16. DENTON, T., and HOWARD, B.D. (1987). A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem. 49, 293-299.
17. DI MONT, D.A., WU, E.Y., IRWIN, L., DELANNEY, L.E., and LANGSTON, J.W. (1992). Production and disposition of 1-methyl-4-phenylpyridine in primary cultures of mouse astrocytes. Glia 5, 48-55.
18. GLOVER, V., GIBB, C., and SANDLER, M. (1986). Monoamine oxidase B (MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissues. Neurosci. Lett. 64, 216-220.
19. GREENE, L.A., and REIN, G. (1977). Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells. Brain Res. 129, 247-263.
20. GIROS, B., MESTIKAWY, S., GODINOT, N., et al. (1992). Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Molec. Pharmacol. 42, 383-390.
21. HEIKKILA, R.E., KINDT, M.V., SONSALLA, P.K., et al. .(1988). Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 85, 6172-6176.
22. +), the neurotoxic metabolite of MPTP. Biochem. Biophys. Res. Comm. 148, 684-690.
23. JAVITCH, J.A., D'AMATO, R.J., STRITTMATTER, S.M., and SNYDER, S.H. (1985). Parkinsonian-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173-2177.
24. JENNER, P., RUPNIAK, N.M., ROSE, S., and KELLY, E. (1984). 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci. Lett. 50, 85-90.
25. +: uptake and toxicity in nonneuronal COS cells expressing dopamine transport cDNA. Ann. Neurol. 32, 109-111.
26. KUTTY, R.K., SANTOSTASI, G., HORNG, J., and KRISHNA, G. (1991). MPTP-induced ATP depletion and cell death in neuroblastoma X glioma hybrid NG 108-15 cells: protection by glucose and sensitization by tetraphenylborate. Toxicol. Appl. Pharmacol. 107, 377-388.
27. LAI, M., GRIFFITHS, H., PALL, H., WILLIMAS, A., and LUNEC, J. (1993). An investigation into the role of reactive oxygen species in the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity using neuronal cell lines. Biochem. Pharmacol. 45, 927-933.
28. LANGSTON, J.W., BALLARD, P., TETRUD, J.W., and IRWIN, I. (1983). Chronic parkinsonism in human due to a product of meperidine-analog synthesis. Science 219, 979-980.
29. LANGSTON, J.W., FORNO, L.S., REBERT, C.S., and IRWIN, I. (1984a). Selective nigra toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res. 292, 390-394.
30. +): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci. Lett. 48, 87-92.
31. LANGSTON, J.W., IRWIN, I., LANGSTON, E.B., and FORNO, L.S. (1984c). Pargyline prevents MPTP-induced parkinsonism in primates. Science 225, 1480-1482.
32. MARINI, A.M., SCHWARTZ, J.P., and KOPIN, I.J. (1989). The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells. J. Neurosci. 9, 3665-3672.
33. + in PC12 pheochromocytoma cells: binding and biological studies. Neurosci. Lett. 94, 349-354.
34. MELAMED, E., ROSENTHAL, J., GLOBUS, M., COHEN, O., and UZZAN, A. (1985). Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA. Brain Res. 342, 401-404.
35. 3H]noradrenaline from human neuroblastoma cells, SH-SY5Y. J. Neurochem. 56, 1810-1815.
36. MYTILINEOU, C., FRIEDMAN, L.K., and DANIAS, P. (1988). Studies on the toxicity of MPTP to dopamine neurons in tissue and cell cultures, in: Progress in Parkinson Research. F. Hefti and W.J. Weiner (eds.) Plenum Press: NY, pp. 127-136.
37. NAGATSU, T., NAKANO, T., KATO, T., and HIGASHIDA, H. (1981). Expression of A and B types of monoamine oxidase in neuroblastoma hybrid cells. Neurochem. Int. 3, 137-142.
38. NAOI, M., SUZUKI, H., KIUCHI, K., TAKAHASHI, T., and NAGATSU, T. (1987). Effects of N-methyl-4-phenylpyridium ion on monoamine oxidase in a clonal rat pheochromocytoma cell line, PC12. J. Neurochem. 48, 1912-1916.
39. +). Neurosci. Lett. 95, 229-235.
40. NICKLAS, W.J., VYAS, I., and HEIKKILA, R.E. (1985). Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridium, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci. 36, 2503-2508.
41. PAHLMAN, S., ODELSTAD, L., LARSSON, E., GROTTE, G., and NILSSON, K. (1981). Phenotypic changes of human neuroblastoma cells in culture induced by 12-o-tetradecanoyl-phorbol-13-acetate. Int. J. Cancer 28, 583-589.
42. +, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J. Med. Chem. 28, 1432-1436.
43. PIFL, C., GIROS, B., and CARON, M.G. (1993). Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neurosci. 13, 4246-4253.
44. RAMSAY, R.R., SALACH, J.I., DADGAR, J., and SINGER, T.P. (1986). Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism. Biochem. Biophys. Res. Commun. 135, 269-275.
45. +. Neurosci. Lett. 75, 323-328.
46. ROSE, R.A., SPENGLER, B.A., and BIEDLER, J.L. (1983). Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 71, 741-749.
47. ROWLES, T.K., SONG, X., and EHRICH, M. (1995). Identification of endpoints affected by exposure of human neuroblastoma cells to neurotoxicants at concentrations below those that affect cell viability. In Vitro Toxicol. 8, 1-11.
48. SALACH, J.I., SINGNER, T.P., CASTAGNOLI, N., and TREVOR, A. (1984). Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidase A and B and suicide inactivation of the enzymes by MPTP. Biochem. Biophys. Res. Commun. 125, 831-835.
49. SAPORITO, M.S., KEIKKILA, R.E., YOUNGATER, S.K., NICKLAS, W.J., and GELLER, H.M. (1992). Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration. J. Pharmacol. Exp. Therap. 260, 1400-1409.
50. + in both electron transport particles and intact mitochondria. Biochem. Biophys. Res. Commun. 161, 809-818.
51. SCHINELLI, S., ZUDDAS, A., KOPIN, I.L., BARKER, J.L., and PORZIO, U. (1988). 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon. J. Neurochem. 50, 1900-1907.
52. SHINKA, T.S., CASTAGNOLI, N., WU, E.Y., HOAG, M.K.P., and TREVOR, A.J. (1987). High-performance liquid chromatography assay for the nigrostriatal toxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B generated metabolites in brain tissues. J. Chromatography 398, 279-287.
53. SCHUBERT, E.E., and KLIER, F.G. (1977). Storage and release of acetylcholine by a clonal cell line. Proc. Natl. Acad. Sci. USA 74, 5184-5188.
54. SINGER, T.P., SALACH, J.I., and CRABTREE, D. (1985). Reversible inhibition and mechanism based inactivation of monoamine oxidase by 1-methyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem. Biophys. Res. Commun. 127, 707-712.
55. + by dopamine is required for MPTP toxicity: Studies in brain synaptosomes and PC12, in: MPTP: A Neurotoxin Producing Parkinsonian Syndrome. S.P. Markey et al., (eds.) Academic Press: San Diego, pp. 191-201.
56. SONG, X., EHRICH, M., FLAHERTY, D., WANG, Y., and CASTAGNOLI, N. (1966). Biotransformation of a tetrahydropyridine analog of MPTP to a fluorescent pyridinium metabolite by neuroblastoma cells. Toxicol. Appl. Pharmacol. 137, 163-172.
57. SONG, X., PERKINS, S., JORTNER, B.S., and EHRICH, M. (1997). Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells. NeuroToxociology, 18, 341-354.
58. SPINA, B.M., SQUINTO, S.P., MILLER, J., LINDSAY, R.M., and HYMAN, C. (1992). Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system. J. Neurochem. 59, 99-106.
59. UHL, G.R., JAVITCH, J.A., and SNYDER, S.H. (1985). Normal MPTP binding in parkinsonian substantia nigra: Evidence for extraneuronal toxin conversion in human brain. Lancet 1, 956-957.
60. UMEMURA, T., NAOI, M., TAKAHASKI, T., et al. (1990). Cytotoxic effect of 1-methyl-4-phenylpyridinium ion human melanoma cell lines, HMV-11 and SK-MEL-44, is dependent on the melanin contents and caused by inhibition of mitochondrial electron transport. Biochem. Med. Metabol. Biol. 44, 51-58.
61. VAUGHAN, P.F., KAYE, D.F., REEVE, H.L., BALL, S.G., and PEERS, C. (1993). Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y. J. Neurochem. 60, 2159-2166.
62. WESTLUND, K.N., DENNEY, R.M., KOCHERSPERGER, L.M., ROSE, R.M., and ABELL, C.W. (1985). Distinct monoamine oxidase A and B populations in primate brain. Science 230, 181-183.
63. WILLETS, J.M., LAMBERT, D.G., and GRIFFITHS, H.R. (1993). Suitability of B65 and SH-SY5Y neuroblastoma cell as model for "in vitro" neurotoxicity testing. Biochem. Soc. Trans. 21, 425s.
64. WU, E.Y., LANGSTON, J.W., and MONTE, D.A. (1992). Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridium and 1-methyl-4-phenylpyridium species in primary cultures of mouse astrocytes. J. Pharmacol. Exp. Therap. 262, 225-262.
65. ZHU, Q.-S., CRIMSY, J., CHEN, K., and SHIN, J.C. (1992). Promotor organization and activity of human monoamine oxidase (MAO) A and B genes. J. Neurosci. 12, 4437-4446.